Partners and Sponsors
As the only patient initiative dedicated to primary aldosteronism, the Foundation is uniquely positioned to provide access to a diverse and engaged constituent base. Our worldwide reach makes us an ideal vector to convene corporate and industry leaders with interest in improving health outcomes.
While giving the Foundation greater financial flexibility to achieve its mission, corporate partners also engage with the organization at various levels to enhance its efforts in advocacy, care delivery, research, and community development.
Other Foundations and Non-Profit Organizations
Since excess aldosterone is involved in numerous diseases, the Foundation is prioritizing relationships with organizations dedicated to advancing co-occurring disorders. Through this effort, shared values are used as a basis to building capacity and achieving common objectives.
Research and Academia
The Foundation partners with research and academic institutions worldwide to, among others, include patients’ lived experiences in the research process, disseminate findings, and leverage implementation research. At the center of this network, medical centers and teaching hospitals play a key role in updating curricula so that healthcare providers can adequately diagnose and treat primary aldosteronism.
Business Development and Technology
Do you offer a product or service that can benefit patients with primary aldosteronism? Do you develop and support portals and clinical applications? Do you specialize in public relations and cause marketing? These are a few of the factors critical to the Foundation’s growth and where partnerships can have a meaningful impact.
Specialty Pharmacy and Biotech
Primary aldosteronism affects up to a billion individuals worldwide. The Foundation is shedding light on this sizeable market by promoting:
- Inclusion of patients in drug trials;
- Dissemination of trials’ secondary data; and
- Tracking of “off-label use” of available drugs.
Government Agencies and Health Payors
To enable the paradigm shift that will lead to optimum care, the Foundation is building partnerships with payors, public health and regulatory agencies so that primary aldosteronism is no longer considered rare, and the needed frameworks are implemented to incentivize diagnosis and treatment at-scale.
Healthcare Systems and Physicians
At-scale provision of care requires involving clinics, hospitals, specialists and primary care physicians so that unmet medical needs are addressed for all affected patients. Online directories and knowledge translation are some of the collaborative efforts deployed by the Foundation to this effect.
Let’s explore partnership opportunities and find ways to tailor your sponsorship! Please complete the form below, and we will contact you upon receipt of your information. Fields marked with a red asterisk are required.